Medical News

Center for Biomedical Research
Founder: Dr. Briant Burke, MD
Boise, Idaho
http://www.cbrmed.org
Telephone: 1-203-353-0158
E-mail: drq10@iglide.net

For Immediate Release:

Boise, Idaho April 2003 — Dr. Briant Burke, MD and founder of the Center for Biomedical Research announced today groundbreaking new treatment for Molluscum Contagiosum. A common childhood skin condition, the malady occurs in children worldwide with an estimated prevalence in the United States of approximately one in 200 children under age 10. Although Molluscum occurs predominantly in pre-adolescent children, it also occurs in sexually active adults, participants in sports with skin-to-skin contact and those with impaired cellular immunity.

Until today, almost all treatment options have involved some degree of pain, discomfort or irritation. The important milestone in treatment is a safe, natural, topical agent derived from plants called ?Virucide? that is used to help alleviate and eliminate the warty skin lesions associated with Molluscum. Fast and effective, Virucide has been clinically tested for safety and efficacy and is satisfaction guaranteed. In a study performed in the offices of 2 family practitioners and one dermatologist in Boise, Idaho, the findings clearly demonstrated that treatment for approximately 21 days dramatically reduced or eliminated lesions entirely. With an estimated one in 200 children under the age of 10 being affected the treatment is being hailed as nothing short of extraordinary.

The following unsolicited, non-compensated testimonials from delighted users share their experience with Virucide. ? When I first contacted you about my 3 year old son?s problem with Molluscum, I was one frustrated Mom. Most information on the subject was negative and I received no uplifting advice from our family practitioner or dermatologist. Thinking we were doomed to helplessly watch our son suffer, we sent off for Virucide. I am absolutely thrilled to report that in three weeks my son has his smooth kissable toddler skin back! Thank you. Shannon Starkville, MS.

From Kristy: ? Dear Dr. Burke: Just wanted to give you a quick update on my son?s Molluscum. The medicine is working wonders!!!. We have only been using it since Thursday, not even a week since we started and already some of the lesions are completely gone. Thank you so much!

About CBR
The Center for Biomedical Research is an independent research institute dedicated to the development of safe, non-drug clinical therapies. All staff physicians are MD?s licensed to practice medicine in Idaho, and maintain appointments and affiliations with leading regional teaching institutions. The center can be contacted by calling 1-203-353-0158. To learn more about ?Virucide? or about Molluscum Contagiosum, you may visit http://www.cbrmed.org or e-mail CBR, Inc. at drq10@iglide.net for additional details.

Virucide is not a drug and contains no drugs. The FDA has not evaluated this product or these claims. Virucide is not intended to diagnose, treat, cure or prevent any disease.

Center for Biomedical Research
Founder: Dr. Briant Burke, MD
Boise, Idaho
http://www.cbrmed.org
Telephone: 1-203-353-0158
E-mail: drq10@iglide.net

For Immediate Release:

Boise, Idaho April 2003 — Dr. Briant Burke, MD and founder of the Center for Biomedical Research announced today groundbreaking new treatment for Molluscum Contagiosum. A common childhood skin condition, the malady occurs in children worldwide with an estimated prevalence in the United States of approximately one in 200 children under age 10. Although Molluscum occurs predominantly in pre-adolescent children, it also occurs in sexually active adults, participants in sports with skin-to-skin contact and those with impaired cellular immunity.

Until today, almost all treatment options have involved some degree of pain, discomfort or irritation. The important milestone in treatment is a safe, natural, topical agent derived from plants called ?Virucide? that is used to help alleviate and eliminate the warty skin lesions associated with Molluscum. Fast and effective, Virucide has been clinically tested for safety and efficacy and is satisfaction guaranteed. In a study performed in the offices of 2 family practitioners and one dermatologist in Boise, Idaho, the findings clearly demonstrated that treatment for approximately 21 days dramatically reduced or eliminated lesions entirely. With an estimated one in 200 children under the age of 10 being affected the treatment is being hailed as nothing short of extraordinary.

The following unsolicited, non-compensated testimonials from delighted users share their experience with Virucide. ? When I first contacted you about my 3 year old son?s problem with Molluscum, I was one frustrated Mom. Most information on the subject was negative and I received no uplifting advice from our family practitioner or dermatologist. Thinking we were doomed to helplessly watch our son suffer, we sent off for Virucide. I am absolutely thrilled to report that in three weeks my son has his smooth kissable toddler skin back! Thank you. Shannon Starkville, MS.

From Kristy: ? Dear Dr. Burke: Just wanted to give you a quick update on my son?s Molluscum. The medicine is working wonders!!!. We have only been using it since Thursday, not even a week since we started and already some of the lesions are completely gone. Thank you so much!

About CBR
The Center for Biomedical Research is an independent research institute dedicated to the development of safe, non-drug clinical therapies. All staff physicians are MD?s licensed to practice medicine in Idaho, and maintain appointments and affiliations with leading regional teaching institutions. The center can be contacted by calling 1-203-353-0158. To learn more about ?Virucide? or about Molluscum Contagiosum, you may visit http://www.cbrmed.org or e-mail CBR, Inc. at drq10@iglide.net for additional details.

Virucide is not a drug and contains no drugs. The FDA has not evaluated this product or these claims. Virucide is not intended to diagnose, treat, cure or prevent any disease.